23. Hemovigilance in Developing Countries

  1. René R. P. De Vries MD1 and
  2. Jean-Claude Faber MD2
  1. Jean-Claude Faber MD

Published Online: 6 AUG 2012

DOI: 10.1002/9781118338179.ch23

Hemovigilance: An Effective Tool for Improving Transfusion Safety

Hemovigilance: An Effective Tool for Improving Transfusion Safety

How to Cite

Faber, J.-C. (2012) Hemovigilance in Developing Countries, in Hemovigilance: An Effective Tool for Improving Transfusion Safety (eds R. R. P. De Vries and J.-C. Faber), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781118338179.ch23

Editor Information

  1. 1

    Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

  2. 2

    Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Author Information

  1. Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Publication History

  1. Published Online: 6 AUG 2012
  2. Published Print: 29 AUG 2012

ISBN Information

Print ISBN: 9780470655276

Online ISBN: 9781118338179

SEARCH

Keywords:

  • hemovigilance in developing countries;
  • transfusion medicine and blood-safety measures in developing countries;
  • lack of facilities, equipment, and material;
  • blood system level;
  • developing countries, overall organization absent;
  • Bes, sites of production segment of blood chain;
  • blood donors, important elements in blood systems;
  • product/process vigilance, prerequisites for HV setting;
  • hemovigilance, basic to comprehensive;
  • WHO and hemovigilance with emphasis on developing countries

Summary

This chapter contains sections titled:

  • Introduction

  • Blood system level

  • Production segment

  • Usage segment

  • Vigilance of donors, recipients, and products/processes in developing countries

  • Proceeding with HV in developing countries

  • WHO and hemovigilance

  • GloSCH: A worldwide HV initiative

  • References